NCT02868229 - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

December 11, 2018

Study Completion Date

December 11, 2018

Conditions

Anemia

Interventions

DRUG

COR-001

OTHER

Placebo

Trial Locations (12)

Novo Nordisk Investigational Site, Great Neck

Novo Nordisk Investigational Site, Astoria

Novo Nordisk Investigational Site, Fresh Meadows

Novo Nordisk Investigational Site, Augusta

Novo Nordisk Investigational Site, Hollywood

Novo Nordisk Investigational Site, Tampa

Novo Nordisk Investigational Site, Chicago

Novo Nordisk Investigational Site, Houston

Novo Nordisk Investigational Site, San Antonio

Novo Nordisk Investigational Site, Northridge

Novo Nordisk Investigational Site, North Brunswick

Novo Nordisk Investigational Site, Providence